Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel

Background: A novel estradiol-based combined oral contraceptive (COC) is currently available in many countries worldwide, including Europe and the US. Based on previous studies, it is expected that this estradiol-based COC will have a reduced hepatic effect compared with COCs containing ethinylestra...

Descripción completa

Detalles Bibliográficos
Autores principales: Klipping, Christine, Duijkers, Ingrid, Parke, Susanne, Mellinger, Uwe, Serrani, Marco, Junge, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585947/
https://www.ncbi.nlm.nih.gov/pubmed/21679006
http://dx.doi.org/10.2165/11591200-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585947/
https://www.ncbi.nlm.nih.gov/pubmed/21679006
http://dx.doi.org/10.2165/11591200-000000000-00000

Ejemplares similares